Equities
  • Price (EUR)17.74
  • Today's Change0.04 / 0.23%
  • Shares traded236.00
  • 1 Year change+25.09%
  • Beta--
Data delayed at least 15 minutes, as of Sep 24 2021 07:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Medical Properties Trust, Inc. is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company's segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants. The Company conducts its operations through MPT Operating Partnership, L.P. The Company acquires and develops healthcare facilities, and leases the facilities to healthcare operating companies under long-term net leases. The Company makes mortgage loans to healthcare operators collateralized by their real estate assets. The Company owns hospitals with approximately 390 facilities and approximately 42,000 licensed beds in eight countries and across three continents.

  • Revenue in USD (TTM)1.41bn
  • Net income in USD517.42m
  • Incorporated2003
  • Employees106.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MPW:NYQ since
announced
Transaction
value
Springstone IncAnnounced15 Jun 202115 Jun 2021Announced-5.69%--
Springstone Inc-Behavioral Health Facility Portfolio(18)Announced15 Jun 202115 Jun 2021Announced-5.69%950.00m
Infracore SADeal completed01 Apr 202101 Apr 2021Deal completed-2.63%--
Priory Group Ltd-Behavioral Health Facilities Portfolio (40)Announced06 Jan 202106 Jan 2021Announced-0.77%1.09bn
Data delayed at least 15 minutes, as of Sep 24 2021 21:10 BST.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image